Canagliflozin Should Have Limitations Based On Renal Function, Panel Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Several advisory committee members on both sides of a 10-5 vote voiced concern about using Janssen’s diabetes drug in patients with moderate renal impairment.